Cohen David Jacques, Glina Sidney
Rua Cincinato Braga, 37 cj 102 - 01233011- Sao Paulo - SP-Brazil.
Curr Drug Targets. 2015;16(5):451-8. doi: 10.2174/1389450116666150202153832.
Erectile dysfunction (ED) is the main and most frequent side effect after radical prostatectomy. Also, ED is the primary impact factor for quality of life after radical prostatectomy. ED post radical prostatectomy is mainly due to lesions in the neurovascular bundles which can occur by partial or total sectioning, by stretching (the most common), or by thermal lesion of the nervous fibers, leading to a condition called "neuropraxia". The term penile rehabilitation (PR) after prostatectomy has been defined as any intervention with the intent of reestablishing preoperative erectile function and includes the isolated or combined use of phosphodiesterase 5 inhibitors (PDE5i), intracavernous injection, vacuum erectile device therapy, and use of intraurethral drugs. The use of intracavernous drugs, of intraurethral prostaglandin and the use of vacuum therapy have a poorly defined role regarding postoperative penile rehabilitation and must be better investigated through further studies. The use of PDE5i as PR is strongly supported by experimental research, but most clinical trials found controversial results.
勃起功能障碍(ED)是根治性前列腺切除术后主要且最常见的副作用。此外,ED是根治性前列腺切除术后生活质量的主要影响因素。根治性前列腺切除术后的ED主要是由于神经血管束受损,这种损伤可能通过部分或完全切断、拉伸(最常见)或神经纤维的热损伤而发生,导致一种称为“神经失用症”的情况。前列腺切除术后阴茎康复(PR)一词被定义为旨在恢复术前勃起功能的任何干预措施,包括单独或联合使用磷酸二酯酶5抑制剂(PDE5i)、海绵体内注射、真空勃起装置治疗以及尿道内用药。海绵体内药物、尿道内前列腺素的使用以及真空治疗在术后阴茎康复方面的作用尚不明确,必须通过进一步研究进行更好的调查。作为阴茎康复使用PDE5i得到了实验研究的有力支持,但大多数临床试验发现结果存在争议。